These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 31677717)
1. Incidence and risk factors of parenteral nutrition-associated liver disease in hospitalized adults: A prospective cohort study. Lakananurak N; Tienchai K Clin Nutr ESPEN; 2019 Dec; 34():81-86. PubMed ID: 31677717 [TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factors of parenteral nutrition-associated liver disease in newborn infants. Koseesirikul P; Chotinaruemol S; Ukarapol N Pediatr Int; 2012 Jun; 54(3):434-6. PubMed ID: 22449297 [TBL] [Abstract][Full Text] [Related]
3. Risk factors for parenteral nutrition–associated liver disease following surgical therapy for necrotizing enterocolitis: A Glaser Pediatric Research Network Study [corrected]. Duro D; Mitchell PD; Kalish LA; Martin C; McCarthy M; Jaksic T; Dunn J; Brandt ML; Nobuhara KK; Sylvester KG; Moss RL; Duggan C J Pediatr Gastroenterol Nutr; 2011 May; 52(5):595-600. PubMed ID: 21464752 [TBL] [Abstract][Full Text] [Related]
4. Parenteral nutrition dysregulates bile salt homeostasis in a rat model of parenteral nutrition-associated liver disease. Koelfat KVK; Schaap FG; Hodin CMJM; Visschers RGJ; Svavarsson BI; Lenicek M; Shiri-Sverdlov R; Lenaerts K; Olde Damink SWM Clin Nutr; 2017 Oct; 36(5):1403-1410. PubMed ID: 28029505 [TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and treatment of parenteral nutrition-associated liver disease. Xu ZW; Li YS Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):586-93. PubMed ID: 23232629 [TBL] [Abstract][Full Text] [Related]
6. The effect of lipid restriction on the prevention of parenteral nutrition-associated cholestasis in surgical infants. Sanchez SE; Braun LP; Mercer LD; Sherrill M; Stevens J; Javid PJ J Pediatr Surg; 2013 Mar; 48(3):573-8. PubMed ID: 23480915 [TBL] [Abstract][Full Text] [Related]
7. Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease. Christensen RD; Henry E; Wiedmeier SE; Burnett J; Lambert DK J Perinatol; 2007 May; 27(5):284-90. PubMed ID: 17344923 [TBL] [Abstract][Full Text] [Related]
8. Rifampicin, not vitamin E, suppresses parenteral nutrition-associated liver disease development through the pregnane X receptor pathway in piglets. Guthrie G; Stoll B; Chacko S; Lauridsen C; Plat J; Burrin D Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G41-G52. PubMed ID: 31604032 [TBL] [Abstract][Full Text] [Related]
9. Early predictors of liver injury in patients on parenteral nutrition. Żalikowska-Gardocka M; Niewada M; Niewiński G; Iżycka M; Ratyńska A; Żurek M; Nawrot A; Przybyłkowski A Clin Nutr ESPEN; 2022 Oct; 51():319-322. PubMed ID: 36184223 [TBL] [Abstract][Full Text] [Related]
12. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil. Fallon EM; Le HD; Puder M Curr Opin Organ Transplant; 2010 Jun; 15(3):334-40. PubMed ID: 20503524 [TBL] [Abstract][Full Text] [Related]
13. Supplemental Parenteral Vitamin E Into Conventional Soybean Lipid Emulsion Does Not Prevent Parenteral Nutrition-Associated Liver Disease in Full-Term Neonatal Piglets. Muto M; Lim D; Soukvilay A; Field C; Wizzard PR; Goruk S; Ball RO; Pencharz PB; Mi S; Curtis J; Wales PW; Turner JM JPEN J Parenter Enteral Nutr; 2017 May; 41(4):575-582. PubMed ID: 26471989 [TBL] [Abstract][Full Text] [Related]
14. Impact of parenteral fat composition on cholestasis in preterm infants. Teng J; Arnell H; Bohlin K; Nemeth A; Fischler B J Pediatr Gastroenterol Nutr; 2015 Jun; 60(6):702-7. PubMed ID: 25633496 [TBL] [Abstract][Full Text] [Related]